These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 11003172)
1. A comparison of HFA-BDP Autohaler with budesonide Turbuhaler in asthma control of adult patients with mild to moderately severe disease. Worth H Respir Med; 2000 Sep; 94 Suppl D():S27-30. PubMed ID: 11003172 [No Abstract] [Full Text] [Related]
2. An overview of the clinical efficacy of HFA-BDP in asthma. Muir JF Respir Med; 2000 Sep; 94 Suppl D():S17-20. PubMed ID: 11003170 [No Abstract] [Full Text] [Related]
3. The relative clinical effectiveness of HFA-BDP and fluticasone propionate in asthma. Fairfax AJ Respir Med; 2000 Sep; 94 Suppl D():S31-6. PubMed ID: 11003173 [No Abstract] [Full Text] [Related]
4. Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control. Worth H; Muir JF; Pieters WR Respiration; 2001; 68(5):517-26. PubMed ID: 11694816 [TBL] [Abstract][Full Text] [Related]
5. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children. Pedersen S; Warner J; Wahn U; Staab D; Le Bourgeois M; Van Essen-Zandvliet E; Arora S; Szefler SJ; Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma. Tatsis G; Kotsifas K; Filaditaki V; Makrantoni G; Boulia S J Int Med Res; 2007; 35(3):361-73. PubMed ID: 17593865 [TBL] [Abstract][Full Text] [Related]
7. Effects of hydrofluoroalkane and dry powder-formulated corticosteroids on sputum inflammatory markers in asthmatic patients. Hauber H; Taha R; Bergeron C; Migounov V; Hamid Q; Olivenstein R Can Respir J; 2006 Mar; 13(2):73-8. PubMed ID: 16550263 [TBL] [Abstract][Full Text] [Related]
8. The comparative safety/efficacy ratio of HFA-BDP. Lipworth BJ Respir Med; 2000 Sep; 94 Suppl D():S21-6. PubMed ID: 11003171 [TBL] [Abstract][Full Text] [Related]
9. Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial. Szefler SJ; Warner J; Staab D; Wahn U; Le Bourgeois M; van Essen-Zandvliet EE; Arora S; Pedersen S; J Allergy Clin Immunol; 2002 Jul; 110(1):45-50. PubMed ID: 12110818 [TBL] [Abstract][Full Text] [Related]
10. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose. Davies RJ; Stampone P; O'Connor BJ Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360 [TBL] [Abstract][Full Text] [Related]
11. Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics. Anderson PB; Langley SJ; Mooney P; Jones J; Addlestone R; Rossetti A; Cantini L J Investig Allergol Clin Immunol; 2002; 12(2):107-13. PubMed ID: 12371526 [TBL] [Abstract][Full Text] [Related]
12. HFA-BDP and its implications for the quiet zone. Tashkin DP Respir Med; 2000 Sep; 94 Suppl D():S37-9. PubMed ID: 11003174 [No Abstract] [Full Text] [Related]
13. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol. Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808 [TBL] [Abstract][Full Text] [Related]
14. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study. Wolthers OD; Walters EG Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone. Horiguchi T; Hayashi N; Ohira D; Torigoe H; Ito T; Hirose M; Sasaki Y; Shiga M; Miyazaki J; Kondo R; Tachikawa S J Asthma; 2006 Sep; 43(7):509-12. PubMed ID: 16939990 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy and safety of budesonide turbuhaler administered once daily with twice the dose of beclomethasone dipropionate using pressurised metered dose inhaler in patients with mild to moderate asthma. Ohaju-Obodo JO; Chukwu C; Okpapi J; Egbagbe E; Ige MO; Chukwuka C; Adedapo DA West Afr J Med; 2005; 24(3):190-5. PubMed ID: 16276692 [TBL] [Abstract][Full Text] [Related]
17. Acute safety of beclomethasone dipropionate in a new CFC-free propellant system in asthmatic patients. Ayres JG; Simmons JL; Stampone P Respir Med; 1999 Jan; 93(1):27-32. PubMed ID: 10464845 [TBL] [Abstract][Full Text] [Related]
18. [A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate]. Ohbayashi H; Adachi M; Ichinose M; Ohta K; Kokubu F; Sano Y; Tamura G; Tohda Y; Hirata K; Yasuba H Arerugi; 2007 Jun; 56(6):577-86. PubMed ID: 17615501 [TBL] [Abstract][Full Text] [Related]